Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen bonded directly to ring carbon of the purine ring...
544263, 544267, 544273, C07D47308
There are described 8-(1-aminocycloalkyl)-1,3-dialckylxantaine, their derivatives and their salts with adenosine antagonist activity. A process for the preparation of said compounds and pharmaceutical compositions containing them as antidepressant, nootropic and psychostimolant drugs are also described.
patent: 4299832 (1981-11-01), Brown et al.
patent: 5068236 (1991-11-01), Suzuki et al.
Linden et al., J. Med. Chem., 31, pp. 745-751; 1988.
Patel et al., Amer. Soc. Pharmcol. and Exptl. Therapeutics, Mol. Pharmacol., 33, 585-591, 1988.
Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
Shah Mukund J.
Sripada Pavanaram K.
8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparati does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212596